J&J’s Rybrevant Results Provide Encouragement After Interim Analysis Sparked Jitters

 
• By Alaric DeArment
J&J announced positive topline results from the Phase III MARIPOSA study of Rybrevant • Source: Shutterstock

More from Clinical Trials

More from R&D